The Samsung Biologic analysis/puff-piece that was cited earlier (in a Chinese newspaper translated by Google Translate - holy sh*t) makes it clear they don't intend to remain only a contract manufacturer - they want to develop drugs.

They already have an investment in CYDY of what - $50m or so? - via deferred accounts payable.

Should we start to think of Samsung as a potential acquirer? $300b market cap at the parent level.

https://www.xianjichina.com/news/details_254102.html